drugset / Trial / NCT00891475
Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate efficacy and safety of Radiofrequency ablation in metastatic renal cell carcinoma patients with primary tumor less than 5 cm before medical treatment. Ablation may allow for reduced morbidity and may increase the likelihood of patients receiving systemic therapy.
Timeline
- Start
- 2008-05
- Primary completion
- 2010-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sunitinib | Small molecule | 50 mg | Oral |